Physician profile
Mark A Hucks
NPI 1902839301
$5,220.95
in general payments reported to CMS, 2019-2025
27 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $16.23 · 2021: $486 · 2022: $3,211 · 2023: $446 · 2024: $252 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,687.40 | 2021-2025 | |
| Abbvie INC. | $291.65 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $139.21 | 2023-2024 | Myfembree |
| Sage Therapeutics, LLC | $121.76 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $83.37 | 2023 | Advincula Delineator Uterine Manipulator |
| Hologic Sales and Service, LLC | $77.41 | 2019-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Shield Therapeutics INC | $76.75 | 2023-2024 | Accrufer |
| Optumhealth Care Solutions, LLC | $75.40 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Astellas Pharma US INC | $73.05 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $59.42 | 2019-2021 | |
| Conmed Corporation | $55.56 | 2023 | Airseal |
| Smith+Nephew, INC. | $52.17 | 2023-2025 | Pico 14, Pico, Pico 7 |
| Daiichi Sankyo INC. | $46.00 | 2019-2023 | Injectafer |
| Kerecis Limited | $45.30 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Duchesnay USA Incorporated | $43.20 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $42.15 | 2019-2021 | |
| Exact Sciences Corporation | $41.65 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $26.57 | 2019 | |
| Novo Nordisk INC | $24.68 | 2019 | |
| Supernus Pharmaceuticals, INC. | $24.61 | 2025 | Qelbree |
| Bayer Healthcare Pharmaceuticals INC. | $23.28 | 2019-2021 | |
| Hydrofera LLC | $22.67 | 2025 | Leukomed Sorbact |
| Minerva Surgical, INC | $21.63 | 2025 | |
| Exeltis, USA INC. | $20.59 | 2022 | |
| Organon LLC | $16.45 | 2024 | |
| Meditrina | $14.89 | 2023 | |
| Agile Therapeutics, INC. | $14.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hucks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.